RE:Today's NRYes, we are aware of Theralase. Most people here would probably agree that it is Telesta's closest competition. TST management is also aware of them and has stated that, as long as MCNA is approved, Theralase will have to do a comparator arm study with MCNA which will push their approval even farther out. TLT is definately a stock to keep an eye on, but if I were buying today, I'd still choose TST.